Comparison of the visual outcomes between PRK-MMC and phakic IOL implantation in high myopic patients

Hashemi, Hassan; Miraftab, Mohammad; Asgari, Soheila

doi:10.1038/eye.2014.115

Cited by 18 publications

(8 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nassiri et al [19] in 2018 in a retrospective study of 55 eyes of 29 patients followed 6 months, the UCDVA was 20/25 or better in 81.5% of the cases. The results of Hashemi et al [20,21] in a study with 53 eyes of 28 patients with sphere −10.22 ± (3.02) were that 72.2% of the eyes had 20/25 or more vision and the safety and efficacy [24][25][26][27] are coincident with our work, especially in the first and second year. According to the results of our study, the endothelial cell losses in percentages were similar to those obtained by the different authors after 2 years of follow-up [24][25][26][27][28].…”

Section: Discussionsupporting

confidence: 85%

Artiflex foldable lens for myopia correction results of 10 years of follow-up

Luna

Ramos-López

Castaño-Fernández

et al. 2019

Eye

View full text Add to dashboard Cite

The aim of this study was to evaluate the long-term efficacy and safety of the Artiflex® lens implant and to follow the evolution of the number of corneal endothelial cells over time. Design It was a retrospective study of an observational case series of patients who underwent surgery at "The INVISION Ophthalmic Hospital" (Almería, Spain) in 2007 and who were followed for 10 years. Methods Setting: Clinical practice. Study population included 53 eyes of 30 patients who underwent an Artiflex® lens implant for the correction of myopia from −4 to −14 D. Each patient included in this study had stable myopia for at least 2 years and a contraindication for corneal refractive surgery. The efficacy index was defined as the quotient between uncorrected distance visual acuity postoperative and best-corrected distance visual acuity (BCDVA) preoperative. The safety index was calculated as the quotient between BCDVA postop and BCDVA preop. Results The average efficacy and safety indices of the lenses implanted were 1.1 (SD 0.30) and 1.06 (SD 0.2) at 10 years of follow-up. In this period of time there has been a loss of 12% of the corneal endothelial cells. The postoperative complications were pigment dispersion in four eyes (7%) of four patients and decentration of phakic intraocular lens in two eyes (4%) of another two patients. Conclusions The Artiflex® foldable phakic lens could be a safe and effective long-term alternative for myopic patients in whom laser surgery was contraindicated.

show abstract

Section: Discussionsupporting

confidence: 85%

Artiflex foldable lens for myopia correction results of 10 years of follow-up

Luna

Ramos-López

Castaño-Fernández

et al. 2019

Eye

View full text Add to dashboard Cite

show abstract

“…5 The use of SMILE for high myopia presents several advantages, namely avoiding the flap created during laser-assisted in situ keratomileusis (LASIK) and subsequent risk of ectasia, the risk of haze in high-myopic patients after photorefractive keratectomy and the invasive procedure on phakic IOL surgery.…”

Section: Introductionmentioning

confidence: 99%

Long-term Results of Small-incision Lenticule Extraction in High Myopia

Yıldırım

Alagöz

Demir

et al. 2016

tjo

View full text Add to dashboard Cite

Objectives:To evaluate two-year results of small-incision lenticule extraction (SMILE) for correction of high myopia.Materials and Methods:Forty-five eyes of 35 patients with mean spherical equivalent (SE) of -7.10±0.95 D who underwent routine SMILE by a single surgeon and were followed for at least 2 years were analyzed by retrospective chart review. SMILE was performed with a Visumax femtosecond laser (Carl Zeiss Meditec, Jena, Germany). Follow-up intervals were at 1, 6, 12, and 24 months after surgery. Uncorrected and best corrected distance visual acuity (CDVA), corneal wavefront measurements, and all complications were recorded.Results:After 2 years, 86% of eyes with plano target had an uncorrected distant visual acuity (VA) of 20/20 or better. Two percent of eyes lost 1 line of CDVA, while 32% gained 1 line. The mean SE after 2 years was -0.30±0.50 D. Corneal total high-order aberrations (HOA) increased from 0.43 to 0.92 μm at postoperative 12 months. There were metallic foreign bodies at the corneal interface in 1 eye of 1 patient which caused no decrease in VA.Conclusion:SMILE for high myopia seems safe and effective in light of two-year follow-up results. The procedure caused a moderate increase in HOA.

show abstract

“…Although PIOL was better than PRK in terms of quality of vision, PRK was an alternative in patients with inadequate anterior chamber depths. 33,34 Another drawback of PRK compared to LASIK is postoperative pain particularly for the first 72 hours due to epithelial removal. 35 Bandage soft contact lenses speed the epithelialization and pain relief after PRK.…”

Section: Discussionmentioning

confidence: 99%

Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia

Tananuvat¹,

Winaikosol²,

Niparugs³

et al. 2021

OPTH

View full text Add to dashboard Cite

Purpose: To evaluate the 12-months outcomes of photorefractive keratectomy (PRK) in patients with high myopia (≥ 6.0 diopters, D) compared with low-to-moderate myopia (< 6.0 D). Patients and Methods: Records of 46 patients (69 eyes) who underwent PRK for myopic and astigmatic correction between October 2015 and December 2018 were reviewed. High myopic eyes (29 eyes) were compared with low-to-moderate myopic eyes (40 eyes). All surgeries were adjunct with 0.02% mitomycin C intraoperatively. Measured outcomes included postoperative uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction spherical equivalent, corneal haze rate, and any complications. Results: At 12 months post-PRK, 26 eyes (89.7%) in the high myopia and 39 eyes (97.5%) in the low-to-moderate myopia group had UDVA ≥ 20/20, (p=0.30). Average postoperative logMAR UDVA at 12 months was −0.04 (20/18) and −0.11 (20/15) for the high myopia and low-to-moderate myopia groups, respectively. No eyes in either group had residual refractive errors >1 D. No eyes in both groups developed significant corneal haze at month 12. No eyes had a loss of greater than two Snellen lines of CDVA at 12 months post-surgery. The efficacy and safety indices at 12 months post-surgery were not significantly different between groups (1.06±0.26 vs.1.14±0.27, p =0.25 and 1.14±0.27 vs 1.17±0.26, p=0.60 for low-to-moderate myopia vs high myopia groups, respectively). Conclusion: PRK with high myopic correction provides excellent refractive outcomes and is safe, compared to those of low-to-moderate myopic correction.

show abstract

Comparison of the visual outcomes between PRK-MMC and phakic IOL implantation in high myopic patients

Cited by 18 publications

References 22 publications

Artiflex foldable lens for myopia correction results of 10 years of follow-up

Artiflex foldable lens for myopia correction results of 10 years of follow-up

Long-term Results of Small-incision Lenticule Extraction in High Myopia

Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia

Contact Info

Product

Resources

About